CAS 1655504-04-3
:Formel:C26H25N3O3
InChl:InChI=1S/C26H25N3O3/c1-2-24(30)29-16-14-18(15-17-29)23-13-12-22(26(27)31)25(28-23)19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h2-13,18H,1,14-17H2,(H2,27,31)
InChI Key:MZPVEMOYADUARK-UHFFFAOYSA-N
SMILES:C=CC(=O)N1CCC(CC1)C2=NC(=C(C=C2)C(=O)N)C3=CC=C(C=C3)OC4=CC=CC=C4
Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
9 Produkte gefunden.
6-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)Nicotinamide
CAS:6-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)NicotinamideFormel:C26H25N3O3Reinheit:98%Molekulargewicht:427.56-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide
CAS:Formel:C26H25N3O3Reinheit:98%Farbe und Form:SolidMolekulargewicht:427.4950Orelabrutinib
CAS:Orelabrutinib (ICP-022) is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK).Formel:C26H25N3O3Reinheit:97.77% - 99.54%Farbe und Form:SolidMolekulargewicht:427.49Ref: TM-T12317
1mg86,00€5mg177,00€1mL*10mM (DMSO)205,00€10mg299,00€25mg492,00€50mg682,00€100mg897,00€500mg1.791,00€Orelabrutinib
CAS:Orelabrutinib is a small-molecule Bruton’s tyrosine kinase (BTK) inhibitor, which is synthesized chemically. This selective inhibitor targets BTK, a key enzyme involved in the B-cell receptor signaling pathway. By binding covalently to cysteine-481 in BTK, orelabrutinib effectively blocks the downstream signaling, leading to apoptosis of malignant B-cells.Formel:C26H25N3O3Reinheit:Min. 95%Molekulargewicht:427.5 g/molOrelabrutinib
CAS:6-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamideFormel:C26H25N3O3Reinheit:98%Molekulargewicht:427.5Orelabrutinib (Standard)
CAS:Orelabrutinib (Standard) is a reference standard for research and analysis in studies involving Orelabrutinib. Orelabrutinib (ICP-022) is an orally active and irreversible inhibitor of Bruton's tyrosine kinase (BTK).Formel:C26H25N3O3Farbe und Form:SolidMolekulargewicht:427.496-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide
CAS:Reinheit:98%Molekulargewicht:427.5039978
